Back to Search
Start Over
Tr-KIT/c-KIT ratio in renal cell carcinoma
- Source :
- Molecular biology reports. 46(5)
- Publication Year :
- 2019
-
Abstract
- Gunes, Sezgin/0000-0002-3103-6482; us altay, diler/0000-0002-0465-8403; abur, ummet/0000-0002-4811-9321 WOS: 000495590600059 PubMed: 31342295 Truncated KIT (tr-KIT) is an alternative variant of c-KIT protein. Previous studies have clearly documented that c-KIT was associated with various oncogenic processes in RCC. However, the biological significance of tr-KIT in RCC development and progression remains unclear. So, it was aimed to investigate the possible association between RCC and tr-KIT which is thought to activate some oncogenic pathways. In this study, Kidney Cancer cDNA Array containing a total of 48 cDNA samples from the normal kidney tissues of 9 healthy subjects and kidney tumor tissues of 10 stage-1, 5 stage-2, 13 stage-3 and 11 stage-4 RCC patients was used for gene expression analysis. Real-Time PCR method was used to measure tr-KIT/c-KIT expression ratios. tr-KIT/c-KIT expression ratio was compared between tumor and normal samples, and statistically correlated with the clinical parameters of RCC patients. tr-KIT/c-KIT expression ratio was approximately 4-times higher in tumor samples than control ones (p = 0.001). Also, tr-KIT/c-KIT expression ratio was approximately two, three and six times higher in Fuhrman nuclear grades 2, 3 and 4 than normal, respectively (p = 0.009). Moreover, clear cell and papillary RCC has a significantly higher level of tr-KIT/c-KIT expression ratio than chromophobe RCC (p = 0.016). In the current study, it was stated for the first time that tr-KIT/c-KIT expression ratio was up-regulated in RCC tissues, and high tr-KIT/c-KIT expression ratio was correlated with more aggressive clinical features and poor patient prognosis. Our results suggest that increased tr-KIT/c-KIT expression ratio might be useful as a prognostic marker for RCC patients. Scientific & Technological Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [118S162] This study was funded by The Scientific & Technological Research Council of Turkey (TUBITAK) (Grant No: 118S162).
- Subjects :
- 0301 basic medicine
Adult
Male
Chromophobe cell
03 medical and health sciences
0302 clinical medicine
Renal cell carcinoma
Complementary DNA
c-KIT
tr-KIT
Gene expression
Genetics
medicine
Biomarkers, Tumor
Humans
Molecular Biology
Carcinoma, Renal Cell
Aged
Neoplasm Staging
Kidney
Fuhrman nuclear grade
business.industry
General Medicine
Middle Aged
medicine.disease
Prognosis
Carcinoma, Papillary
Kidney Neoplasms
Up-Regulation
Gene Expression Regulation, Neoplastic
Alternative Splicing
Proto-Oncogene Proteins c-kit
030104 developmental biology
medicine.anatomical_structure
Biological significance
030220 oncology & carcinogenesis
Case-Control Studies
Cancer research
Female
business
Kidney cancer
Clear cell
Subjects
Details
- ISSN :
- 15734978
- Volume :
- 46
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- Molecular biology reports
- Accession number :
- edsair.doi.dedup.....24083e194229b9e814366ec23d84de36